Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Multiple Drug Resistance. Found 10 abstracts

Teijaro CN, Munagala S, Zhao S, Sirasani G, Kokkonda P, Malofeeva EV, Hopper-Borge E, Andrade RB. Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump. Journal of medicinal chemistry. 2014 Dec 26;57(24):10383-90.   PMCID: PMC4281106
Bookman MA. Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic. International Journal of Gynecological Cancer. 2005 May;15 Suppl 1:12-7.
Hudes G. Boosting bioavailability of topotecan: what do we gain?. J Clin Oncol. 2002 Jul;20(13):2918-9.
Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochemical pharmacology. 2002 Apr;63(7):1219-28.
Chen ZS, Aoki S, Komatsu M, Ueda K, Sumizawa T, Furukawa T, Okumura H, Ren XQ, Belinsky MG, Lee K, Kruh GD, Kobayashi M, Akiyama S. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function. International journal of cancer. 2001 Jul;93(1):107-13.
Treat J, Damjanov N, Huang C, Zrada S, Rahman A. Liposomal-encapsulated chemotherapy: preliminary results of a phase I study of a novel liposomal paclitaxel. Oncology (Huntingt). 2001 May;15(5 Suppl 7):44-8.
Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 2001 Oct;61(19):7225-32.
Lee K, Klein-Szanto AJ, Kruh GD. Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells. Journal of the National Cancer Institute. 2000 Dec 06;92(23):1934-40.
O'Brien ML, Vulevic B, Freer S, Boyd J, Shen H, Tew KD. Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein. The Journal of pharmacology and experimental therapeutics. 1999 Dec;291(3):1348-55.
Zhang X, Minale L, Zampella A, Smith CD. Microfilament depletion and circumvention of multiple drug resistance by sphinxolides. Cancer Res. 1997 Sep;57(17):3751-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Multiple Drug Resistance

Multiple Drug Resistance Human metabolism pharmacology drug effects Animal Antineoplastic Agents antagonists & inhibitors US Gov't Support-PHS Non-US Gov't Support Enzyme Inhibitors genetics Multidrug Resistance-Associated Proteins Antitumor Drug Screening Assays pharmacokinetics Female ATP-Binding Cassette Transporters 3T3 Cells Neoplasm Drug Resistance Phytogenic Antineoplastic Agents Paclitaxel Mice Cell Survival chemistry Cell Membrane Type I DNA Topoisomerases Cell Cycle Cultured Tumor Cells analogs & derivatives Polymers Phenotype Ovarian Neoplasms Cytotoxins pd [Pharmacology] Doxorubicin Biological Transport administration & dosage drug therapy HL-60 Cells aa [Analogs & Derivatives] Adenosinetriphosphatase P-Glycoprotein Antineoplastic Antimetabolites Breast Neoplasms me [Metabolism] Anthracycline Antibiotics Methotrexate Neoplasm Proteins Dinitrophenols HEK293 Cells ge [Genetics] 103882-84-4 (gemcitabine) Colchicine adverse effects 73-40-5 (Guanine) Immunoblotting Recombinant Proteins US Gov't Support-Non-PHS Neoplasm DNA KB Cells Phytogenic) 0 (Antineoplastic Agents de [Drug Effects] 0 (Proto-Oncogene Proteins c-bcl-2) P-Glycoproteins chemical synthesis Alkaloids Alkylating Antineoplastic Agents Transfection 0 (cyclin-dependent kinase Inhibitor p21) human) EC 3-6-1 (PMS2 protein Folic Acid Molecular Cloning Isoquinolines Topotecan EC 2-1-1-63 (O(6)-Methylguanine-DNA Methyltransferase) Complementary DNA DNA Fragmentation 85622-93-1 (temozolomide) Actins Glioma O(6)-Methylguanine-DNA Methyltransferase Strychnos Alkylating) 0 (Antineoplastic Agents 0 (Cyclins) physiology Pyrans Gene Expression Regulation Protein p53 ultrastructure Intestinal Absorption Daunorubicin Phase I Clinical Trials Porifera Neoplasm) 0 (DNA toxicity 33069-62-4 (Paclitaxel) Drug Delivery Systems 23214-92-8 (Doxorubicin) mammalian) 0 (MLH1 protein Smooth Muscle-Vascular 4342-03-4 (Dacarbazine) Leucovorin Local Neoplasm Recurrence Polyglutamic Acid Glutathione Cytochalasin B ch [Chemistry] Tritium Antineoplastic) 0 (Antimetabolites Vincristine Anion Transport Proteins Adenosine Triphosphatases 19916-73-5 (O(6)-benzylguanine) 0 (Protein p53) Osmolar Concentration Marine Toxins Etoposide Deoxycytidine ph [Physiology] therapeutic use Type II DNA Topoisomerases Cyclins tu [Therapeutic Use] Cell Proliferation Immunohistochemistry 0 (DNA-Binding Proteins) Sterols Dacarbazine Indole Alkaloids DNA Repair Enzymes bi [Biosynthesis] 951-77-9 (Deoxycytidine) Proto-Oncogene Proteins c-bcl-2 EC 3-6-1-3 (Adenosinetriphosphatase) Adenosine Triphosphate Drug Interactions Carrier Proteins Fluorescent Antibody Technique Acrylates Guanine pa [Pathology] DNA-Binding Proteins Reverse Transcriptase Polymerase Chain Reaction Microfilaments 0 (Neoplasm Proteins) Prostate dt [Drug Therapy] EC 6-5-1 (DNA Repair Enzymes) Biological Availability Acridines
Last updated on Monday, May 04, 2020